about
Argon laser iridoplasty as primary treatment for acute angle closure glaucoma: a prospective clinical study.Hypotensive effect of pilocarpine after argon laser trabeculoplasty.Common sequence variants in the LOXL1 gene in pigment dispersion syndrome and pigmentary glaucoma.Surgical avulsion of the iris to treat selected cases of neovascular glaucoma.Long-term efficacy of latanoprost in primary congenital glaucomaOverview of the [corrected] travoprost /timolol BAK-free fixed combination.24-hour intraocular pressure and ocular perfusion pressure in glaucoma.Efficacy and safety of trabeculectomy vs nonpenetrating surgical procedures: a systematic review and meta-analysis.Safety and efficacy of travoprost solution for the treatment of elevated intraocular pressure.Gonioscopic findings in patients with type 1 neurofibromatosis (Von Recklinghausen disease).Long-term outcomes of prostaglandin analog versus timolol maleate in ocular hypertensive or primary open-angle glaucoma patients in Europe.Peak intraocular pressure and glaucomatous progression in primary open-angle glaucoma.Risk factors associated with progression in exfoliative glaucoma patients.Outcomes of conjunctival compression sutures for hypotony after glaucoma filtering surgery.Evidence of the neuroprotective role of citicoline in glaucoma patients.Twenty-four-hour intraocular pressure and blood pressure levels with bimatoprost versus latanoprost in patients with normal-tension glaucoma.Intracameral tissue plasminogen activator for resolution of fibrin clots after glaucoma filtering proceduresColor Doppler assessment of normal ocular blood flowPower Doppler sonography enhances visualization of orbital vessels[Color Doppler echography of the orbit. Its normal aspects and pathological conditions with vascular involvement]Incidence of disc hemorrhage in glaucomaEfficacy of sulodexide as adjunct in trabeculectomy. A two-year randomized clinical studyThe effect of endarterectomy on ocular blood velocityA new device for ocular massage after trabeculectomyThe rate of progression and ocular perfusion pressure in the Low-pressure Glaucoma Treatment StudyCircadian intraocular pressure and blood pressure reduction with timolol 0.5% solution and timogel 0.1% in patients with primary open-angle glaucomaUntreated 24-h intraocular pressures measured with Goldmann applanation tonometry vs nighttime supine pressures with Perkins applanation tonometryDynamic contour tonometry and goldman applanation tonometry: correlation with intracameral assessment of intraocular pressureTopographic optic disc changes after successful trabeculectomy evaluated using spectral domain optical coherence tomographyOutcomes of using a sutureless bovine pericardial patch graft for Ahmed glaucoma valve implantationTwenty-four hour efficacy with preservative free tafluprost compared with latanoprost in patients with primary open angle glaucoma or ocular hypertensionGinkgo biloba extract improves visual field damage in some patients affected by normal-tension glaucomaLong-term 24-hour intraocular pressure control with travoprost monotherapy in patients with primary open-angle glaucomaElevated intraocular pressure in patients with acromegalyEffect of trabeculectomy and canaloplasty on intra-ocular pressure modifications after postural changes in open-angle glaucomaA rare case of endophthalmitis after bleb needle revision for glaucoma Xen® gel stentPre-operative conjunctival flora in patients with local and/or systemic risk factors for post cataract surgery infection in Northern Italy
P50
Q31114832-B2987C9C-4F42-41FB-BA7D-8052012C0464Q33310267-C0CB2C0B-8B26-458D-844F-A9DE1C6960E5Q33638501-0B0FC76F-1E9B-4CD3-BB4C-E03E33B55B6FQ36674857-9280DF0C-AAE2-4491-BDA7-A7D77C28A0A9Q37474626-9390CD22-B6A5-45BD-AB69-810B34B7F9FFQ37987586-ED5065DC-5134-46F9-A263-F2320420F811Q38065385-0BD5F8FC-AFC6-4C35-9578-3CC436E9263EQ38155442-D8BEAFCD-179A-4C7D-913C-044FC028B61AQ38443489-558C0AA3-C691-4117-A446-F25E142ED348Q42460520-BD844BD3-FBFE-42BA-A724-BB378A62B6C0Q42610751-F2ED7596-005E-4798-801A-D45318915CCCQ42620687-76D5403F-38FF-4866-84E6-2882BEC8EE5FQ42629156-45993CF5-C40A-42AF-B1D3-E421901F90C8Q45411714-AA748A2A-6DB9-4BB3-9523-97D5713B61A3Q46311534-7BD586F1-3681-41F5-A2FC-7E12064D0783Q46513068-AB45661C-2419-4E65-B65F-6C25A417898DQ67983348-DCB682C0-C46C-4117-8E71-390C639FB4C0Q70508335-C1B0DFAA-D3FE-40B6-9393-962BD9CD0CE0Q70873374-A9C03BA9-6B40-4A28-83D8-79DD5E078D3CQ72417093-C7D2B0F0-A847-4E5D-A965-1CFB7F21DD82Q72560727-F5435A8E-4CC6-4F45-95F4-381A3586D10BQ73580131-DCC33537-58A4-47AC-8E20-87B5E0B37EA8Q74307352-223F1503-EF53-4D7E-9251-BC0C0FCBD65BQ78001248-7DB55F70-6F89-4269-9F79-237C6FFCDEC9Q82138581-81F90F3B-3456-402E-9720-3414D9E1C52FQ82645528-94F3AF0F-87FF-4411-A9FD-F22B246C1388Q84977531-CC29E8B7-CBAD-4120-A1DF-B2F8C3BB3B7BQ85066190-E071C83D-B323-4E8A-AA5F-AB487BE97465Q86044396-77C07DFF-061E-4D18-A61C-C7FB030CFEF9Q86360583-F9E4F423-0C5E-41CC-A51F-3D709DB61D7FQ86814488-451003FB-4C9B-4FBD-A597-03FBE9E0DEB8Q87689216-CFDC4FBF-396C-459B-A172-AC19FD10AF39Q87790496-0C162330-2ED1-4041-8E6D-6E81AA0767FFQ87852710-7D378ABE-1324-4FD3-8E9D-9C73607D842BQ88129957-7CFEB886-8B19-4B0B-AFFD-80C1C3285DEDQ90271581-950FB41A-A394-4F06-9EC8-BE145DA6D581Q96582209-5581ED69-D742-44A9-A350-6014D49331B5
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
研究者
@zh
name
L Quaranta
@ast
L Quaranta
@en
L Quaranta
@es
L Quaranta
@nl
type
label
L Quaranta
@ast
L Quaranta
@en
L Quaranta
@es
L Quaranta
@nl
prefLabel
L Quaranta
@ast
L Quaranta
@en
L Quaranta
@es
L Quaranta
@nl
P31
P496
0000-0002-5462-1713